Riskpilot← Back to searchSign inGet full accessCephalus AB
ABActiveOrg 5561879403Vipstigen 12General medical practice activities · NACE 8621Est. 19740 employees
Revenue 2025
SEK 0
EBITDA margin
—
+101% vs 2024
Equity ratio
55.6%
Financial strength
Net profit 2025
SEK 4,5M
+221% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK 1K | +101% |
| Net profit | SEK 4,5M | +221% |
| Total assets | SEK 17,7M | +32% |
| Equity | SEK 9,8M | +62% |
| Employees | 0 | — |
Legal name
Cephalus AB
Org number
5561879403
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 augusti 1974
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarpraktik, musikverksamhet samt förvalta värdepapper och fast egendom samt därmed förenlig verksamhet.
Address
Vipstigen 12
Phone
+4642282759
Email
johan.neuro@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −19 | 37 | −10 | −123 | 1 |
| Depreciation & amort. | −411 | −403 | −342 | −392 | −323 |
| EBIT | −430 | −366 | −352 | −515 | −322 |
| Net financials | 2 043 | 2 357 | 2 809 | −7 749 | 4 190 |
| Profit before tax | 2 228 | 2 528 | 3 149 | −3 683 | 4 450 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 228 | 2 528 | 3 149 | −3 683 | 4 450 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16 703 | 17 350 | 18 219 | 13 358 | 17 661 |
| Equity | 6 273 | 7 801 | 10 330 | 6 047 | 9 817 |
| Long-term debt | 8 646 | 8 853 | 7 639 | 5 867 | 7 599 |
| Short-term debt | 1 621 | 594 | 153 | 1 408 | 222 |
| Total debt | 10 267 | 9 447 | 7 792 | 7 275 | 7 821 |
EBITDA margin
100000.0%
This company
15.8%
Market median
+632811% vs market
20212025
Equity ratio
55.6%
This company
38.2%
Market median
+46% vs market
20212025
Return on equity
45.3%
This company
18.4%
Market median
+146% vs market
20212025
Net profit margin
445000000.0%
This company
8.1%
Market median
+5493827060% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2025 – 2025 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cephalus AB 
Cephalus Care ABBoard members of Cephalus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rickard Mats Yngve Julin | Audit | 0 companies |
| Sven Johan Nyberg | Board of Directors | 0 companies |
| Fabiola Nyberg | Deputy Board Member | 0 companies |
| Helena Susanna Nyberg | Board of Directors | 0 companies |
| Rosi Marie Katarina Nyberg | Deputy Board Member | 0 companies |